China State FDA Reforms Expected, But When?
This article was originally published in PharmAsia News
China's State FDA insists it will align the country's pharmaceutical and medical device regulations with international standards. The question on manufacturers' minds is, how soon
You may also be interested in...
Chinese Congress Passes New Law Covering Product Liability For Drugs And Devices, Along With Medical Malpractice
BEIJING - Chinese President Hu Jintao has signed an extensive new "Tort Law of the People's Republic of China" covering medical malpractice, product liability and related provisions that could affect companies across the life sciences with operations in China
HONG KONG - When China's State FDA released figures for cases of adverse drug reactions in late January, it touched on an underreported issue and one that may prove difficult to tackle
BEIJING - China's State FDA has issued a wide-ranging compilation of good manufacturing practice standards for medical devices, set to become effective one year from now, that for the first time will cover all manufacturers across the country, according to lawyers who closely monitor the sector